Current data has a 15-minute delay. Please Sign Up /
Sign In to get real-time quotes.
stocks
/
NASDAQ-ABUS
/
A
Arbutus Biopharma
ABUS
ABUSArbutus BiopharmaNASDAQ
Add to watchlist
--
At close :
--
Post market
A
Arbutus Biopharma
ABUS
(ABUS)
--
--(0.00 %)
Summary
Options
Financials
News
Filings
Profile
ABUS Chart
See on advanced chart >
...
All
...
D
...
W
...
M
...
5m
...
Volume629.58k
Turnover2.14M
P/E(TTM)--
Turnover %0.43%
P/E(Static)--
Market Cap648.06M
P/B6.06
Shares189.49M
52 Week Range
2.210
4.725
Day Range
3.285
3.445
About
Arbutus Biopharma Corporation was incorporated the British Columbia on October 6, 2005. The company is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms...
Read More
Highlight
A clinical-stage biopharmaceutical company that developing therapeutics for hepatitis B virus